Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Cryer

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The American Journal of Gastroenterology|April 26, 2006
A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?Byron Cryer
The American Journal of Gastroenterology|September 8, 2005
NSAID-associated deaths: the rise and fall of NSAID-associated GI mortalityByron Cryer
Current Gastroenterology Reports|November 7, 2003
The role of cyclooxygenase selective inhibitors in the gastrointestinal tractByron Cryer
Gastroenterology Clinics of North America|May 19, 2009
Management of patients with high gastrointestinal risk on antiplatelet therapyByron Cryer
The American Journal of Managed Care|January 7, 2003
Gastrointestinal safety of low-dose aspirinByron Cryer
Journal of Managed Care Pharmacy : JMCP|April 13, 2013
Management of NSAID-associated upper gastrointestinal problemsByron Cryer
Gastrointestinal Endoscopy Clinics of North America|September 28, 2011
Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleedingIris Lee, Byron Cryer
American Journal of Therapeutics|September 25, 2014
Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safetyBill H McCarberg, Byron Cryer
Proceedings (Baylor University. Medical Center)|March 16, 2026
Preventing colorectal cancer deathsF David Winter, Byron Cryer
Mayo Clinic Proceedings|October 11, 2002
Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?Byron Cryer, Douglas C Bauer
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The American Journal of Gastroenterology|April 26, 2006
A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?Byron Cryer
The American Journal of Gastroenterology|September 8, 2005
NSAID-associated deaths: the rise and fall of NSAID-associated GI mortalityByron Cryer
Current Gastroenterology Reports|November 7, 2003
The role of cyclooxygenase selective inhibitors in the gastrointestinal tractByron Cryer
Gastroenterology Clinics of North America|May 19, 2009
Management of patients with high gastrointestinal risk on antiplatelet therapyByron Cryer
The American Journal of Managed Care|January 7, 2003
Gastrointestinal safety of low-dose aspirinByron Cryer
Journal of Managed Care Pharmacy : JMCP|April 13, 2013
Management of NSAID-associated upper gastrointestinal problemsByron Cryer
Gastrointestinal Endoscopy Clinics of North America|September 28, 2011
Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleedingIris Lee, Byron Cryer
American Journal of Therapeutics|September 25, 2014
Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safetyBill H McCarberg, Byron Cryer
Proceedings (Baylor University. Medical Center)|March 16, 2026
Preventing colorectal cancer deathsF David Winter, Byron Cryer
Mayo Clinic Proceedings|October 11, 2002
Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?Byron Cryer, Douglas C Bauer
Pageof 6